vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Seneca Foods Corp (SENEB). Click either name above to swap in a different company.

Seneca Foods Corp is the larger business by last-quarter revenue ($508.3M vs $487.7M, roughly 1.0× CLOVER HEALTH INVESTMENTS, CORP.). Seneca Foods Corp runs the higher net margin — 8.8% vs -10.1%, a 18.9% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 1.1%). Seneca Foods Corp produced more free cash flow last quarter ($22.9M vs $-69.0M). Over the past eight quarters, Seneca Foods Corp's revenue compounded faster (77.1% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Seneca Foods Corporation is an American food processor and distributor headquartered in Fairport, New York, United States. Seneca Foods Corporation conducts its business almost entirely in food packaging, which contributed to about 98% of the company's fiscal year net sales in 2017. Canned vegetables represented 65%, fruit products represented 23%, frozen fruit and vegetables represented 11% and fruit chip products represented 1% of the total food packaging net sales. Non-food packaging sales...

CLOV vs SENEB — Head-to-Head

Bigger by revenue
SENEB
SENEB
1.0× larger
SENEB
$508.3M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+43.6% gap
CLOV
44.7%
1.1%
SENEB
Higher net margin
SENEB
SENEB
18.9% more per $
SENEB
8.8%
-10.1%
CLOV
More free cash flow
SENEB
SENEB
$91.9M more FCF
SENEB
$22.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
SENEB
SENEB
Annualised
SENEB
77.1%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
SENEB
SENEB
Revenue
$487.7M
$508.3M
Net Profit
$-49.3M
$44.8M
Gross Margin
16.4%
Operating Margin
-10.1%
11.8%
Net Margin
-10.1%
8.8%
Revenue YoY
44.7%
1.1%
Net Profit YoY
-123.2%
205.4%
EPS (diluted)
$6.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SENEB
SENEB
Q4 25
$487.7M
$508.3M
Q3 25
$496.6M
$460.0M
Q2 25
$477.6M
$297.5M
Q1 25
$462.3M
$345.8M
Q4 24
$337.0M
$502.9M
Q3 24
$331.0M
$425.5M
Q2 24
$356.3M
$304.7M
Q1 24
$346.9M
$162.2M
Net Profit
CLOV
CLOV
SENEB
SENEB
Q4 25
$-49.3M
$44.8M
Q3 25
$-24.4M
$29.7M
Q2 25
$-10.6M
$14.9M
Q1 25
$-1.3M
$601.0K
Q4 24
$-22.1M
$14.7M
Q3 24
$-9.2M
$13.3M
Q2 24
$7.4M
$12.7M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
SENEB
SENEB
Q4 25
16.4%
Q3 25
13.4%
Q2 25
14.1%
Q1 25
4.5%
Q4 24
9.8%
Q3 24
24.5%
10.1%
Q2 24
30.3%
14.0%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
SENEB
SENEB
Q4 25
-10.1%
11.8%
Q3 25
-4.9%
9.0%
Q2 25
-2.2%
7.8%
Q1 25
-0.3%
0.6%
Q4 24
-6.4%
5.1%
Q3 24
-2.7%
5.8%
Q2 24
2.0%
8.3%
Q1 24
-6.5%
2.5%
Net Margin
CLOV
CLOV
SENEB
SENEB
Q4 25
-10.1%
8.8%
Q3 25
-4.9%
6.5%
Q2 25
-2.2%
5.0%
Q1 25
-0.3%
0.2%
Q4 24
-6.6%
2.9%
Q3 24
-2.8%
3.1%
Q2 24
2.1%
4.2%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
SENEB
SENEB
Q4 25
$6.48
Q3 25
$4.29
Q2 25
$2.14
Q1 25
$0.10
Q4 24
$2.10
Q3 24
$1.90
Q2 24
$1.80
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SENEB
SENEB
Cash + ST InvestmentsLiquidity on hand
$78.3M
$33.3M
Total DebtLower is stronger
$275.8M
Stockholders' EquityBook value
$308.7M
$713.9M
Total Assets
$541.0M
$1.2B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SENEB
SENEB
Q4 25
$78.3M
$33.3M
Q3 25
$18.1M
Q2 25
$12.1M
Q1 25
$42.7M
Q4 24
$194.5M
$5.3M
Q3 24
$288.0M
$9.5M
Q2 24
$254.8M
$5.5M
Q1 24
$208.3M
$4.5M
Total Debt
CLOV
CLOV
SENEB
SENEB
Q4 25
$275.8M
Q3 25
$280.2M
Q2 25
$293.9M
Q1 25
$369.9M
Q4 24
$416.2M
Q3 24
$504.6M
Q2 24
$572.1M
Q1 24
$604.8M
Stockholders' Equity
CLOV
CLOV
SENEB
SENEB
Q4 25
$308.7M
$713.9M
Q3 25
$340.9M
$672.9M
Q2 25
$344.2M
$644.2M
Q1 25
$336.1M
$633.0M
Q4 24
$341.1M
$612.8M
Q3 24
$342.2M
$598.9M
Q2 24
$324.9M
$588.9M
Q1 24
$292.5M
$582.9M
Total Assets
CLOV
CLOV
SENEB
SENEB
Q4 25
$541.0M
$1.2B
Q3 25
$559.7M
$1.4B
Q2 25
$575.0M
$1.2B
Q1 25
$583.7M
$1.2B
Q4 24
$580.7M
$1.2B
Q3 24
$653.0M
$1.5B
Q2 24
$674.2M
$1.4B
Q1 24
$671.8M
$1.4B
Debt / Equity
CLOV
CLOV
SENEB
SENEB
Q4 25
0.39×
Q3 25
0.42×
Q2 25
0.46×
Q1 25
0.58×
Q4 24
0.68×
Q3 24
0.84×
Q2 24
0.97×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SENEB
SENEB
Operating Cash FlowLast quarter
$-66.9M
$31.1M
Free Cash FlowOCF − Capex
$-69.0M
$22.9M
FCF MarginFCF / Revenue
-14.1%
4.5%
Capex IntensityCapex / Revenue
0.4%
1.6%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$168.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SENEB
SENEB
Q4 25
$-66.9M
$31.1M
Q3 25
$12.1M
$29.3M
Q2 25
$5.4M
$53.7M
Q1 25
$-16.3M
$91.9M
Q4 24
$34.8M
$117.7M
Q3 24
$50.0M
$75.5M
Q2 24
$44.8M
$50.3M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
SENEB
SENEB
Q4 25
$-69.0M
$22.9M
Q3 25
$11.4M
$21.8M
Q2 25
$4.8M
$42.4M
Q1 25
$-16.5M
$81.4M
Q4 24
$33.3M
$108.7M
Q3 24
$49.6M
$70.0M
Q2 24
$44.4M
$38.3M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
SENEB
SENEB
Q4 25
-14.1%
4.5%
Q3 25
2.3%
4.7%
Q2 25
1.0%
14.3%
Q1 25
-3.6%
23.5%
Q4 24
9.9%
21.6%
Q3 24
15.0%
16.4%
Q2 24
12.5%
12.6%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
SENEB
SENEB
Q4 25
0.4%
1.6%
Q3 25
0.1%
1.6%
Q2 25
0.1%
3.8%
Q1 25
0.0%
3.0%
Q4 24
0.5%
1.8%
Q3 24
0.1%
1.3%
Q2 24
0.1%
4.0%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
SENEB
SENEB
Q4 25
0.70×
Q3 25
0.99×
Q2 25
3.61×
Q1 25
152.87×
Q4 24
8.03×
Q3 24
5.68×
Q2 24
6.04×
3.98×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

SENEB
SENEB

Canned Vegetables$430.2M85%
Fruit$34.6M7%
Frozen$29.3M6%
Manufactured Product Other$10.8M2%
Snack$3.4M1%

Related Comparisons